2080 Ventures · Investor research
61 investors focused on Biotech for pre-ipo companies
Compare 61 investors focused on Biotech for pre-ipo companies. Review the selection, investor types and reported focus with 2080 Ventures.
What this selection covers
This guide contains 61 distinct directory identities matching sectors: Biotech; business stages: Pre-IPO. Counts describe Investor Atlas coverage, not the size of the market or currently available capital.
Pre-IPO is a business development stage, not a funding round. Ask each investor how it defines this milestone and what evidence it expects.
Investor types represented: Venture Capital (49), Corporate Venture Capital (6), Angel Investor (4), Family Office (3).
Prepare a focused approach
Explain the development pathway, validation milestones and capital needed to reach the next evidence point.
For Pre-IPO, show the evidence already achieved, the next milestone and a budget connecting the raise to that milestone. Confirm expected round size and ownership.
- Check the current mandate and recent investments.
- Confirm check size, lead or follow preference, and company eligibility.
- Identify the relevant partner and published pitch route.
- Explain your customer evidence, raise and specific reason for approaching this investor.
Explore the 61 matching investors
Listed alphabetically, without ranking by performance or likelihood of investment. Full profiles, investment criteria and available contact details require sign-in.
| Investor | Investor type | Research |
|---|---|---|
 5A5AM Ventures | Venture Capital | View profile ↗ |
 8V8VC | Venture Capital | View profile ↗ |
 ABABAB (Atlantic Business Angels Booster) | Angel Network | View profile ↗ |
 ABAbingworth | Venture Capital | View profile ↗ |
 ACAccretive Ventures | Venture Capital | View profile ↗ |
 ADAdvanced Technology Ventures | Venture Capital | View profile ↗ |
 ALAlumni Ventures | Venture Capital | View profile ↗ |
 AMAmadeus Capital Partners | Venture Capital | View profile ↗ |
 ANAndreessen Horowitz | Venture Capital | View profile ↗ |
 ASAscension Ventures | Venture Capital, Accelerator, Corporate Venture Capital | View profile ↗ |
 ATAtlas Venture | Venture Capital | View profile ↗ |
 BABain Capital | Venture Capital | View profile ↗ |
 BABain Capital Ventures | Venture Capital, Corporate Venture Capital | View profile ↗ |
 BABalderton Capital | Venture Capital | View profile ↗ |
 BIBienville Capital | Family Office | View profile ↗ |
 BPBP Ventures | Venture Capital, Corporate Venture Capital | View profile ↗ |
 CACatalio Capital Management | Venture Capital | View profile ↗ |
 DBDBJ Capital | Venture Capital | View profile ↗ |
 FIFirst Round Capital | Venture Capital | View profile ↗ |
 FLFlagship Pioneering | Venture Capital | View profile ↗ |
 FLFloodgate | Venture Capital | View profile ↗ |
 FOForbion Capital Partners | Venture Capital | View profile ↗ |
 GEGeneral Atlantic | Venture Capital | View profile ↗ |
 GIGilde Healthcare | Venture Capital | View profile ↗ |
 GLGlobal Founders Capital | Venture Capital, Family Office | View profile ↗ |
 GRGranite Asia | Venture Capital | View profile ↗ |
 GRGreat Eagle Holdings | Corporate Venture Capital | View profile ↗ |
 HAHarriet Ventures | Private Equity | View profile ↗ |
 INIndex Ventures | Venture Capital | View profile ↗ |
 ININNO-APAC | Accelerator | View profile ↗ |
 INIntegra Holdings | Venture Capital | View profile ↗ |
 ISIsrael Biotech Fund | Venture Capital | View profile ↗ |
 JAJake Posner | Angel Investor | View profile ↗ |
 KHKhosla Ventures | Venture Capital | View profile ↗ |
 LELevensohn Venture Partners | Venture Capital | View profile ↗ |
 LILightstone Ventures | Venture Capital | View profile ↗ |
 MIMichael Wieser | Angel Investor | View profile ↗ |
 NJNJF Capital | Venture Capital | View profile ↗ |
 NONovo Holdings | Venture Capital, Corporate Venture Capital | View profile ↗ |
 OROrbiMed | Private Equity | View profile ↗ |
 PFPfizer Venture Investments | Venture Capital, Corporate Venture Capital | View profile ↗ |
 POPolaris Partners | Venture Capital | View profile ↗ |
 PSPsyMed Ventures | Venture Capital | View profile ↗ |
 PUPureos Bioventures | Venture Capital | View profile ↗ |
 SESentor Investments | Family Office | View profile ↗ |
 SHShefqet Avdullau | Angel Investor | View profile ↗ |
 SHShenzhen Capital Group | Venture Capital | View profile ↗ |
 SOSofinnova Partners | Venture Capital | View profile ↗ |
 SVSV Health Investors | Venture Capital | View profile ↗ |
 TATarget Global | Venture Capital | View profile ↗ |
 THThe Column Group | Venture Capital | View profile ↗ |
 TPTPG Biotech | Venture Capital | View profile ↗ |
 TRTrue Ventures | Venture Capital | View profile ↗ |
 TVTVM Capital | Venture Capital | View profile ↗ |
 VEVenrock | Venture Capital | View profile ↗ |
 VEVensana Capital | Venture Capital | View profile ↗ |
 VEVersant Ventures | Venture Capital | View profile ↗ |
 VIViola Ventures | Venture Capital | View profile ↗ |
 WEWellcome Trust | Public Fund | View profile ↗ |
 WEWestern Technology Investment | Venture Capital | View profile ↗ |
 ZAZaid Naima | Angel Investor | View profile ↗ |
Related investor guides
United Kingdom · Biotech · Venture Capital
130 Venture Capital investors focused on Biotech targeting United Kingdom
205A8V
ABUnited States · Biotech · Venture Capital
212 Venture Capital investors focused on Biotech targeting United States
19205A8VBiotech · Venture Capital
309 Venture Capital investors focused on Biotech
+N19205APre-IPO
1,052 investors for pre-ipo companies
.4
01
10
13Albania · Pre-IPO
16 investors targeting Albania for pre-ipo companies
AP
AU
BO
CRAlgeria · Pre-IPO
12 investors targeting Algeria for pre-ipo companies
AP
BO
DN
ENHow these guides are compiled. Source-reported criteria may change. A listing does not confirm current investment activity.